Event Date

Sep 8

2022

ARE WE THERE YET? PROGRESS AND PITFALLS WITH SCALING UP PrEP DELIVERY

Since oral PrEP was first approved for use in 2012, dozens of countries have approved the product and use is expanding. But the pace of scale-up has been slower than expected and PrEP remains out of reach for many who may benefit from it.

Continue Reading

Event Date

Jul 31

2022

AIDS 2022 SCIENTIFIC WORKSHOP | OUR NEXT SHOT: EFFECTIVELY DELIVERING INJECTABLE CABOTEGRAVIR FOR PrEP

This workshop will explore what is needed to ensure that introductory research and programs are strategically designed, user-centered, and appropriately resourced to support successful rollout of CAB PrEP.

Continue Reading

Event Date

Jun 2

2022

SHE DECIDES: SUPPORTING PrEP DECISION-MAKING AMONG ADOLESCENT GIRLS AND YOUNG WOMEN IN A MULTI-PRODUCT PrEP MARKET

As we move toward a multi-product HIV prevention market, adolescent girls and young women must be empowered to choose an HIV prevention product that meets their needs.

Continue Reading

Event Date

Feb 24

2022

WHAT’S NEXT FOR CAB PrEP?

In this webinar, we explore ongoing and completed research on CAB PrEP, learn about the recently released FDA guidance, and hear from a panel of implementers and policymakers on what is needed to advance introduction of this new HIV prevention product.

Continue Reading
Page 1 of 1